Azoniaspiro derivatives, process for their preparation and pharmaceutical compositions containing them
申请人:SYNTEX (U.S.A.) INC.
公开号:EP0012071A1
公开(公告)日:1980-06-11
Compounds of the formula
wherein R1 and R2 are the same or different and are C1 to-C6 alkyl; C5 or C6 cycloalkyl; C5 or C6 cycloalkenyl; phenyl, optionally substituted with a substitutent selected from the group C1 to C6 alkyl, C1 to C6 alkoxy and halo; or C4 or C5 heterocyclic aryl, the heteroatom selected from the group oxygen, nitrogen and sulfur;
n is the integer 4 or 5; and
X is a pharmaceutically acceptable anion.
These compounds are useful as anticholinergic agents.
The compounds of Formula (I) are prepared by reacting a compound represented by formula
with a compound of the formula X(CH2)nX, wherein R1, R2, X and n are defined above.
式(I)化合物 其中R1和R2相同或不同,且为C1~C6烷基;C5或C6环烷基;C5或C6环烯基;苯基,任选被选自C1~C6烷基、C1~C6烷氧基和卤代的取代基取代;或C4或C5杂环芳基,杂原子选自氧、氮和硫;n为整数4或5;X为药学上可接受的阴离子。 这些化合物可用作抗胆碱能剂。 式(I)化合物是通过将式代表的化合物与式X(CH2)nX的化合物反应制备的,其中R1、R2、X和n如上定义。